For: | Li C, Xu N, Li YQ, Wang Y, Zhu ZT. Inhibition of SW620 human colon cancer cells by upregulating miRNA-145. World J Gastroenterol 2016; 22(9): 2771-2778 [PMID: 26973415 DOI: 10.3748/wjg.v22.i9.2771] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v22/i9/2771.htm |
Number | Citing Articles |
1 |
Yanling Ding, Chunfu Zhang, Jiahui Zhang, Nannan Zhang, Tao Li, Jie Fang, Yi Zhang, Feiyang Zuo, Zehua Tao, Shengnan Tang, Wei Zhu, Huabiao Chen, Xiaochun Sun. miR-145 inhibits proliferation and migration of breast cancer cells by directly or indirectly regulating TGF-β1 expression. International Journal of Oncology 2017; 50(5): 1701 doi: 10.3892/ijo.2017.3945
|
2 |
E. Shaw, N. Massaro, N. T. Brockton. The role of vitamin D in hepatic metastases from colorectal cancer. Clinical and Translational Oncology 2018; 20(3): 259 doi: 10.1007/s12094-017-1735-x
|
3 |
Xin Huang, Xuan Xu, Huajing Ke, Xiaolin Pan, Jiaoyu Ai, Ruyi Xie, Guilian Lan, Yang Hu, Yao Wu. microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway. European Journal of Histochemistry 2022; 66(2) doi: 10.4081/ejh.2022.3333
|
4 |
Li Ma, Ling-Ling Li. miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1. Cell Transplantation 2019; 28(9-10): 1299 doi: 10.1177/0963689719861063
|
5 |
Jie Li, Xu Li, Lei Wu, Meili Pei, Huijin Li, Yu Jiang. miR‐145 inhibits glutamine metabolism through c‐myc/GLS1 pathways in ovarian cancer cells. Cell Biology International 2019; 43(8): 921 doi: 10.1002/cbin.11182
|
6 |
Wuer Zhou, Yue Yang, Wei Wang, Chenglin Yang, Zhi Cao, Xiaoyu Lin, Huifen Zhang, Yuansong Xiao, Xiaoming Zhang. Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p. Cell Cycle 2024; 23(6): 645 doi: 10.1080/15384101.2024.2353554
|
7 |
Sonia Reimondez-Troitiño, José V. González-Aramundiz, Juan Ruiz-Bañobre, Rafael López-López, María J. Alonso, Noemi Csaba, María de la Fuente. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells. European Journal of Pharmaceutics and Biopharmaceutics 2019; 142: 449 doi: 10.1016/j.ejpb.2019.07.016
|
8 |
Nazila Mozammel, Mohammad Amini, Behzad Baradaran, Seyedeh Zahra Bahojb Mahdavi, Seyed Samad Hosseini, Ahad Mokhtarzadeh. The function of miR-145 in colorectal cancer progression; an updated review on related signaling pathways. Pathology - Research and Practice 2023; 242: 154290 doi: 10.1016/j.prp.2022.154290
|
9 |
Sha Liu, Guozhen Gao, Dexiong Yan, Xiangjun Chen, Xingwei Yao, Shuzhong Guo, Guirong Li, Yu Zhao. Retracted:Effects of miR‐145‐5p throughNRASon the cell proliferation, apoptosis, migration, and invasion in melanoma by inhibitingMAPKandPI3K/AKTpathways. Cancer Medicine 2017; 6(4): 819 doi: 10.1002/cam4.1030
|
10 |
Mohammad Roshani, Danial Molavizadeh, Sara Sadeghi, Ameneh Jafari, Fatemeh Dashti, Seyed Mohammad Ali Mirazimi, Sahar Ahmadi Asouri, Ali Rajabi, Michael R. Hamblin, Ali Arash Anoushirvani, Hamed Mirzaei. Emerging roles of miR-145 in gastrointestinal cancers: A new paradigm. Biomedicine & Pharmacotherapy 2023; 166: 115264 doi: 10.1016/j.biopha.2023.115264
|
11 |
Mu-Sheng Zeng. The Long and Short Non-coding RNAs in Cancer Biology. Advances in Experimental Medicine and Biology 2016; 927: 391 doi: 10.1007/978-981-10-1498-7_15
|
12 |
Lijuan Zhang, Gang Feng, Xinyan Zhang, Yawen Ding, Xiaojuan Wang. microRNA-630 promotes cell proliferation and inhibits apoptosis in the HCT116 human colorectal cancer cell line. Molecular Medicine Reports 2017; 16(4): 4843 doi: 10.3892/mmr.2017.7159
|
13 |
Surasa Nagachinta, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, Maria de la Fuente. Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics 2020; 12(2): 189 doi: 10.3390/pharmaceutics12020189
|
14 |
Ghofrane Lahmadi, Aida Lahmar, Mansour Znati, Mohamed Tahar Elaieb, Mohamed Larbi Khouja, Roberta Ascrizzi, Guido Flamini, Abdel Halim Harrath, Leila Chekir‐Ghedira, Hichem Ben Jannet. Chemical Composition and Cytotoxic Activity of Eucalyptus torquata Luehm. and Eucalyptus salmonophloia F. Muell. Trunk Bark Essential Oils against Human SW620 and MDA‐MB‐231 Cancer Cell Lines. Chemistry & Biodiversity 2021; 18(11) doi: 10.1002/cbdv.202100315
|
15 |
Gizem Ors-Kumoglu, Sultan Gulce-Iz, Cigir Biray-Avci. Therapeutic microRNAs in human cancer. Cytotechnology 2019; 71(1): 411 doi: 10.1007/s10616-018-0291-8
|
16 |
Abdullah M Alhadheq, Rana Alhadheq, Saad Alkahtani. Aberrant expression of miR-143/miR-223/miR4478 and miR145 as prognostic factor for colorectal cancer patients. Journal of King Saud University - Science 2024; 36(11): 103494 doi: 10.1016/j.jksus.2024.103494
|
17 |
Huajia Dai, Kezhu Hou, Zujin Cai, Qi Zhou, Song Zhu. Low‑level miR‑646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression. Oncology Letters 2017; doi: 10.3892/ol.2017.7032
|
18 |
Rosa Hernández, Ester Sánchez-Jiménez, Consolación Melguizo, Jose Prados, Ana Rosa Rama. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Reports 2018; 51(11): 563 doi: 10.5483/BMBRep.2018.51.11.116
|